This is the text extract for Consultation on Actavis agreement. Closes 13 February 2009, browse documents here.

29 January 2009

Subsidy and Price reduction proposal relating to Acitretin, Bezafibrate, Diazepam and Disulfiram

PHARMAC and Actavis Australia Ltd have entered into a provisional agreement relating to the supply of acitretin (Neotigason), bezafibrate (Bezalip Retard), diazepam (Stesolid) and disulfiram (Antabuse). In summary, the proposal would result in: § a reduction in the price for Neotigason, Bezalip Retard and Stesolid from 1 April 2009 (including additional savings from a rebate to the new price for subsidies paid from 1 December 2008 until 1 April 2009); subsidy and delisting protection for Neotigason and Bezalip Retard until 30 June 2012.

§

Feedback sought PHARMAC welcomes feedback on this proposal. To provide feedback, please submit it in writing by Friday 13 February 2009 to: Mike Bignall Therapeutic Group Manager PHARMAC Email: mike.bignall@pharmac.govt.nz Fax: 04 460 4995 Post: PO Box 10 254, Wellington 6143

All feedback received before the closing date will be considered by PHARMAC’s Board (or Chief Executive acting under delegated authority) prior to making a decision on this proposal. Details of the proposal § The following pharmaceuticals would be listed in Section B and in Part II of Section H of the Pharmaceutical Schedule at the following prices and subsidies from 1 April 2009:

Pack size 100 100 30 5 5 100 Current price and subsidy $94.75 $203.70 $7.60 $27.83 $33.89 $24.30 Proposed price and subsidy $75.80 $162.96 $5.70 $25.05 $30.50 $24.30

Chemical Acitretin Acitretin Bezafibrate Diazepam Diazepam Disulfiram

Presentation Cap 10 mg Cap 25 mg Tab long-acting 400 mg Rectal tube 5 mg Rectal tube 10 mg Tab 200 mg

Brand Neotigason Neotigason Bezalip Retard Stesolid Stesolid Antabuse

§

Neotigason and Bezalip Retard would have subsidy protection until 30 June 2012.

A258467 - T08-261

Background Information Acitretin is a retinoid drug used for oral treatment of severe cases of psoriasis and of disorders of keratinization. Bezafibrate is a fibrate drug used for the treatment of hyperlipidaemia. Diazepam rectal preparations are used to treat severe anxiety, agitation and convulsions caused by epilepsy or fever. Disulfiram is a drug used to support the treatment of chronic alcoholism by producing an acute sensitivity to alcohol.

A258467 - T08-261